These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18039340)

  • 1. Efficacy of pregabalin in the treatment of trigeminal neuralgia.
    Obermann M; Yoon MS; Sensen K; Maschke M; Diener HC; Katsarava Z
    Cephalalgia; 2008 Feb; 28(2):174-81. PubMed ID: 18039340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trigeminal neuralgia treated with pregabalin in family medicine settings: its effect on pain alleviation and cost reduction.
    Pérez C; Saldaña MT; Navarro A; Martínez S; Rejas J
    J Clin Pharmacol; 2009 May; 49(5):582-90. PubMed ID: 19299534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America.
    Xochilcal-Morales M; Castro EM; Guajardo-Rosas J; Obregón TN; Acevedo JC; Chucan JM; Plancarte-Sanchez R; Davila G; Wajsbrot D; Guerrero M; Vinueza R
    Int J Clin Pract; 2010 Aug; 64(9):1301-9. PubMed ID: 20487048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia.
    Sharma U; Griesing T; Emir B; Young JP
    Am J Ther; 2010; 17(6):577-85. PubMed ID: 20393345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief.
    Stacey BR; Barrett JA; Whalen E; Phillips KF; Rowbotham MC
    J Pain; 2008 Nov; 9(11):1006-17. PubMed ID: 18640074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported outcomes in subjects with painful trigeminal neuralgia receiving pregabalin: evidence from medical practice in primary care settings.
    Pérez C; Navarro A; Saldaña MT; Martínez S; Rejas J
    Cephalalgia; 2009 Jul; 29(7):781-90. PubMed ID: 19522052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone.
    Lemos L; Flores S; Oliveira P; Almeida A
    Clin J Pain; 2008 Jan; 24(1):64-75. PubMed ID: 18180639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin beneficial effects on sleep quality or health-related quality of life are poorly correlated with reduction on pain intensity after an 8-week treatment course.
    Perez-Lloret S; Rojas GM; Menoni MC; Ruiz G; Velásquez C; Rodriguez H; Rey MV; Cardinali AD;
    Clin Neuropharmacol; 2012; 35(1):21-4. PubMed ID: 22156921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
    Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP
    Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of clinical efficacy of amitriptyline and pregabalin in postherpetic neuralgia.
    Achar A; Chakraborty PP; Bisai S; Biswas A; Guharay T
    Acta Dermatovenerol Croat; 2012; 20(2):89-94. PubMed ID: 22726281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings.
    Navarro A; Saldaña MT; Pérez C; Torrades S; Rejas J
    Pain Med; 2010 May; 11(5):719-31. PubMed ID: 20345618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study.
    Pérez C; Navarro A; Saldaña MT; Masramón X; Rejas J
    Clin Ther; 2010 Jul; 32(7):1357-70. PubMed ID: 20678683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.
    Solak Y; Biyik Z; Atalay H; Gaipov A; Guney F; Turk S; Covic A; Goldsmith D; Kanbay M
    Nephrology (Carlton); 2012 Nov; 17(8):710-7. PubMed ID: 22909343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial.
    Siddall PJ; Cousins MJ; Otte A; Griesing T; Chambers R; Murphy TK
    Neurology; 2006 Nov; 67(10):1792-800. PubMed ID: 17130411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy.
    Ifuku M; Iseki M; Hidaka I; Morita Y; Komatus S; Inada E
    Pain Med; 2011 Jul; 12(7):1112-6. PubMed ID: 21692969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.
    Arnold LM; Emir B; Murphy TK; Zeiher BG; Pauer L; Scott G; Petersel D
    Clin Ther; 2012 May; 34(5):1092-102. PubMed ID: 22503162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin as mono- or add-on therapy for patients with refractory chronic neuropathic pain: a post-marketing prescription-event monitoring study.
    Lampl C; Schweiger C; Haider B; Lechner A
    J Neurol; 2010 Aug; 257(8):1265-73. PubMed ID: 20221770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.